Frank Pallone,
H.R. 3 Title V Subtitle B
(2021)
“ For the Food and Drug Administration to support improvements to the technological infrastructure for reporting and analysis of adverse events associated with the use of drugs and biological products, for each of fiscal years 2022 through 2031, $12,500,000.”. ”
